Intensive glucose lowering and the risk of vascular events and premature death in patients with decreased kidney function: the ADVANCE trial
<p>To assess effects of intensive glucose‐control on the risk of major clinical outcomes according to estimated glomerular filtration rate (eGFR) levels in type 2 diabetes. Among 11,140 ADVANCE trial participants, 11,096 participants with baseline eGFR measurements were included, classified in...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Wiley
2019
|